Sanara MedTech Inc.
SMTIAs of the close on Sep 25, 2026
Price
$35.06
Market cap
$322M
P/E (diluted TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
EPS (TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Sanara MedTech Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 16 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 5, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Independent insiders buying near the same time
- 2019-10-15–2019-10-15: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2016-03-30–2016-03-30: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2015-12-14–2015-12-14: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2022-11-08 | Fleming Zachary B. · Chief Executive Officer | Common Stock | S — Open market or private sale | −417 | 33.00 | SEC filing |
| 2022-11-04 | Fleming Zachary B. · Chief Executive Officer | Common Stock | S — Open market or private sale | −563 | 33.00 | SEC filing |
| 2022-11-02 | Fleming Zachary B. · Chief Executive Officer | Common Stock | S — Open market or private sale | −20 | 33.02 | SEC filing |
| 2022-09-22 | Bowman Shawn M. · Pres. - Strategic Partnerships | Common Stock | S — Open market or private sale | −340 | 28.56 | SEC filing |
| 2022-09-22 | Bowman Shawn M. · Pres. - Strategic Partnerships | Common Stock | S — Open market or private sale | −660 | 27.54 | SEC filing |
| 2022-07-06 | Fleming Zachary B. · Chief Executive Officer | Common Stock | S — Open market or private sale | −665 | 22.00 | SEC filing |
| 2022-07-06 | Fleming Zachary B. · Chief Executive Officer | Common Stock | S — Open market or private sale | −750 | 23.00 | SEC filing |
| 2022-07-05 | Fleming Zachary B. · Chief Executive Officer | Common Stock | S — Open market or private sale | −265 | 21.45 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-04 | Salamone Ann Beal · Director | Common Stock | A — Grant, award, or other acquisition | +4,154 | SEC filing |
| 2026-06-04 | Nixon Ronald T · Director, 10% owner | Common Stock | A — Grant, award, or other acquisition | +4,154 | SEC filing |
| 2026-06-04 | Myers Keith G · Director | Common Stock | A — Grant, award, or other acquisition | +4,385 | SEC filing |
| 2026-06-04 | DeSutter Robert Andrew · Director | Common Stock | A — Grant, award, or other acquisition | +5,539 | SEC filing |
| 2026-06-04 | Major Eric D · Director | Common Stock | A — Grant, award, or other acquisition | +4,846 | SEC filing |
| 2026-06-04 | Ortwein Sara N · Director | Common Stock | A — Grant, award, or other acquisition | +4,616 | SEC filing |
| 2026-06-04 | TANZBERGER ERIC D · Director | Common Stock | A — Grant, award, or other acquisition | +5,308 | SEC filing |
| 2026-06-04 | Mack Roszell III · Director | Common Stock | A — Grant, award, or other acquisition | +5,308 | SEC filing |
Showing 8 of 32 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2022-12-02 | Bowman Shawn M. · Other | Common Stock | D — Disposition to the issuer | −4,414 | SEC filing |
| 2020-02-10 | STUCKERT JAMES W · Director, 10% owner | Common Stock | J — Other acquisition or disposition | −7,229 | SEC filing |
| 2020-02-10 | Fleming Zachary B. · President - Surgical Div. | Common Stock | J — Other acquisition or disposition | −13,555 | SEC filing |
| 2020-02-10 | Bowman Shawn M. · President - Wound Care Div. | Common Stock | J — Other acquisition or disposition | −13,555 | SEC filing |
| 2020-02-10 | McNeil Michael D. · Chief Financial Officer | Common Stock | J — Other acquisition or disposition | −8,097 | SEC filing |
| 2020-02-10 | Fleming Zachary B. · President - Surgical Div. | Common Stock | J — Other acquisition or disposition | −4,550 | SEC filing |
| 2020-02-10 | Thorpe Kenneth E · Director | Common Stock | J — Other acquisition or disposition | −2,410 | SEC filing |
| 2020-02-10 | Salamone Ann Beal · Director | Common Stock | J — Other acquisition or disposition | −2,410 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.